Immunology 1991: Vol 73 Index

7 Pages·1991·1.5 MB·English

ADONIS 0019280591001924
Author Index
AKERBLOM L. see BROLIDEN P. A. BUNDICK R. V. see HENDERSON D. J.
AKERLEY B. see NEL A. E. BuRSSENS G. see SCHEERLINCK J.-P. Y.
ALVAREZ A. see FONTECHA A.-M. BurTON G. F., Kosco M. H., SZAKAL A. K. & Tew J. G. Iccosomes and
ALVAREZ A. see NAVARRO R. the secondary antibody response, 271
ANDERSSON M., GOLDSCHMIDT T. J., MICHAELSSON E., LARSSON A. &
HOLMDAHL R. T-cell receptor V# haplotype and complement compo- CALLARD R. E. see Smitu S. H.
nent CS play no significant role for the resistance to collagen-induced CAMBIER J. C. see HAUSCHILDT S.
arthritis in the SWR mouse, 191 CamPBELL A. K. see Davies E. V.
ANDREW P. W. see WALKER L. CARLSTEN H., HOLMDAHL R. & TARKOWSKI A. Analysis of the genetic
Apt A. S., KRAMNIK I. B. & Moroz A. M. Regulation of T-cell encoding of oestradiol suppression of delayed-type hypersensitivity in
proliferative responses by cells from solid lung tissue of M. tuberculo- (NZB x NZW) F; mice, 186
sis-infected mice, 173 CHALLACOMBE §. J. see O'HAGAN D. T.
ARDAVIN C. see FONTECHA A.-M. CHAMPION B. R., HUTCHINGS P., RAYNER D. C., PAGE K., T1TE J., COOKE
ARDAVIN C. see NAVARRO R. A. & Riott I. M. Jn vitro regulation of thyroglobulin (Tg) autoanti-
AusseL C. see BREITTMAYER J.-P. body production by Tg-specific T-cell lines and hybridomas, 415
AustruP F., KUCHARZIK T. & KOLscH E. Cremophor EL as an CHANG N.-S., BOACKLE R. J. & Leu R. W. Characterization of Cl
adjuvant affecting immunoglobulin class switch in the immune inhibitor binding to neutrophils, 95
response to the thymus-independent antigen «(1— >3) dextran B COHEN P. L. see DAvIGNON J.-L.
1355 S, 508 CoLuins A. M., ROBERTON D. M., HOSKING C. S. & FLANNERY G. R.
Oral immunization with xenogeneic antibodies stimulates the produc-
BARBACANE R. C. see ConTI P. tion of systemic and mucosal anti-idotypic antibodies, 388
BARCLAY R. see WALKER L. Conti P., Dempsey R. A., REALE M., BARBACANE R. C., PANARA M. R.,
Be.t E. B. see SARAWAR S. R. BONGRAZIO M. & Mier J. W. Activation of human natural killer cells
BeN-BassaT M. see FRICKE H. by lipopolysaccharide and generation of interleukin-alpha, beta,
BertoTTo A. see SPINOZZ1 F. tumour necrosis factor and interleukin-6. Effect of IL-1 receptor
BESSLER W. see HAUSCHILDT S. antagonist, 450
BLANK M. see FRICKE H. CooKE A. see CHAMPION B. R.
BOACKLE R. J. see CHANG N.-S. Costa J. J. see Dastycu J.
Bocas J. M., Koo C. H. & Goetzu E. J. Down-regulation of receptor Cousin J.-L. see BREITTMAYER J.-P.
antigen in leukotriene By-induced chemotactic deactivation of human Covas M. J. see Pinto L.
polymorphonuclear leucocytes, 212 CUNHA F. Q. see RIBEIRO R. A.
BONGRAZIO M. see Conti P.
BoreckyY L. see KONTSEK P. DAHLGREN U. I. H., WoLp A. E., HANSON L. A. & Miptvept T.
Boss J. M., Laster S. M. & GoopinG L. R. Sensitivity to tumour Expression of a dietary protein in E. coli renders it strongly antigenic
necrosis factor-mediated cytolysis is unrelated to manganous super- to gut lymphoid tissue, 394
oxide dismutase messenger RNA levels among transformed mouse Dari A. see SILEGHEM M.
fibroblasts, 309 Dastycu J., Costa J. J., THOMPSON H. L. & METCALFE D. D. Mast cell
BOTTAZZI B. see KANKOVA M. adhesion to fibronectin, 478
BouwMaN E. see LJZERMANS J. N. M. Davies E. V., HALLETT M. B. & CAMPBELL A. K. Localized superoxide
BOWERN N. A. see HUNTER N. release by neutrophils can be provoked by a cytosolic calcium ‘cloud’,
BrEEL M. see LimPENs J. 228
BREITTMAYER J.-P., AusseEL C., FARAHIFAR D., Cousin J.-L. & FEHL- Davies M. C. see O' HAGAN D. T.
MANN M. A phosphatidic acid-sensitive intracellular pool of calcium DaviGNON J.-L., VALLIN-DAVIGNON M., COHEN P. L. & EISENBERG R. A.
is released by anti-CD3 in Jurkat T cells, 134 Targeting of T-B interaction using heteroconjugate antibody, |
BricGs S., Price M. R. & TENDLER S. J. B. Immune recognition of linear Davis S. S. see O'HAGAN D. T.
epitopes in peptide fragments of epithelial mucins, 505 De LA FUENTE M., Det Rio M., FERRANDEZ M. D. & HERNANZ A.
BROLIDEN K. see BROLIDEN P. A. Modulation of phagocytic function in murine peritoneal macro-
BROLIDEN P. A., MAKITALO B., AKERBLOM L., ROSEN J., BROLIDEN K.., phages by bombesin, gastrin-releasing peptide and neuromedin C,
Utter G., JonDAL M., Norrsy E. & WAHREN B. Identification of 205
amino acids in the V3 region of gp120 critical for virus neutralization DE BAETSELIER P. see SCHEERLINCK J.-P. Y.
by human HIV-1-specific antibodies, 371 DE BAETSELIER P. see SILEGHEM M.
Brom C., Brom J. & KONIG W. G protein activation and mediator De Bruin R. W. F. see IsZERMANS J. N. M.
release from human neutrophils and platelets after stimulation with Dex Rio M. see DE LA FUENTE M.
sodium fluoride and receptor-mediated stimuli, 287 Dempsey R. A. see Conti P.
Brom J. see Brom C. DIAMANT M. see KAPPEL M.
Brooks C. G. see HOLSCHER M. DimMock N. J. see McLain L.
Brown F. see Francis M. J. D1Ixon G. see WALKER L.
BRYANT A. see FRANZ A. DUCHAINE J. see Mosser D. D.
Brys L. see SCHEERLINCK J.-P. Y.
BueNnaFe A. C. & RITTENBERG M. B. Maturation of the antibody EISENBERG R. A. see DAVIGNON J.-L.
response to a protein-coupled form of the organophosphorus toxin ERMAK T. H. see Pappo J.
soman, 398 Evans G. F. see ZUCKERMAN S. H.
512
ADONIS 0019280591001924
Author Index
AKERBLOM L. see BROLIDEN P. A. BUNDICK R. V. see HENDERSON D. J.
AKERLEY B. see NEL A. E. BuRSSENS G. see SCHEERLINCK J.-P. Y.
ALVAREZ A. see FONTECHA A.-M. BurTON G. F., Kosco M. H., SZAKAL A. K. & Tew J. G. Iccosomes and
ALVAREZ A. see NAVARRO R. the secondary antibody response, 271
ANDERSSON M., GOLDSCHMIDT T. J., MICHAELSSON E., LARSSON A. &
HOLMDAHL R. T-cell receptor V# haplotype and complement compo- CALLARD R. E. see Smitu S. H.
nent CS play no significant role for the resistance to collagen-induced CAMBIER J. C. see HAUSCHILDT S.
arthritis in the SWR mouse, 191 CamPBELL A. K. see Davies E. V.
ANDREW P. W. see WALKER L. CARLSTEN H., HOLMDAHL R. & TARKOWSKI A. Analysis of the genetic
Apt A. S., KRAMNIK I. B. & Moroz A. M. Regulation of T-cell encoding of oestradiol suppression of delayed-type hypersensitivity in
proliferative responses by cells from solid lung tissue of M. tuberculo- (NZB x NZW) F; mice, 186
sis-infected mice, 173 CHALLACOMBE §. J. see O'HAGAN D. T.
ARDAVIN C. see FONTECHA A.-M. CHAMPION B. R., HUTCHINGS P., RAYNER D. C., PAGE K., T1TE J., COOKE
ARDAVIN C. see NAVARRO R. A. & Riott I. M. Jn vitro regulation of thyroglobulin (Tg) autoanti-
AusseL C. see BREITTMAYER J.-P. body production by Tg-specific T-cell lines and hybridomas, 415
AustruP F., KUCHARZIK T. & KOLscH E. Cremophor EL as an CHANG N.-S., BOACKLE R. J. & Leu R. W. Characterization of Cl
adjuvant affecting immunoglobulin class switch in the immune inhibitor binding to neutrophils, 95
response to the thymus-independent antigen «(1— >3) dextran B COHEN P. L. see DAvIGNON J.-L.
1355 S, 508 CoLuins A. M., ROBERTON D. M., HOSKING C. S. & FLANNERY G. R.
Oral immunization with xenogeneic antibodies stimulates the produc-
BARBACANE R. C. see ConTI P. tion of systemic and mucosal anti-idotypic antibodies, 388
BARCLAY R. see WALKER L. Conti P., Dempsey R. A., REALE M., BARBACANE R. C., PANARA M. R.,
Be.t E. B. see SARAWAR S. R. BONGRAZIO M. & Mier J. W. Activation of human natural killer cells
BeN-BassaT M. see FRICKE H. by lipopolysaccharide and generation of interleukin-alpha, beta,
BertoTTo A. see SPINOZZ1 F. tumour necrosis factor and interleukin-6. Effect of IL-1 receptor
BESSLER W. see HAUSCHILDT S. antagonist, 450
BLANK M. see FRICKE H. CooKE A. see CHAMPION B. R.
BOACKLE R. J. see CHANG N.-S. Costa J. J. see Dastycu J.
Bocas J. M., Koo C. H. & Goetzu E. J. Down-regulation of receptor Cousin J.-L. see BREITTMAYER J.-P.
antigen in leukotriene By-induced chemotactic deactivation of human Covas M. J. see Pinto L.
polymorphonuclear leucocytes, 212 CUNHA F. Q. see RIBEIRO R. A.
BONGRAZIO M. see Conti P.
BoreckyY L. see KONTSEK P. DAHLGREN U. I. H., WoLp A. E., HANSON L. A. & Miptvept T.
Boss J. M., Laster S. M. & GoopinG L. R. Sensitivity to tumour Expression of a dietary protein in E. coli renders it strongly antigenic
necrosis factor-mediated cytolysis is unrelated to manganous super- to gut lymphoid tissue, 394
oxide dismutase messenger RNA levels among transformed mouse Dari A. see SILEGHEM M.
fibroblasts, 309 Dastycu J., Costa J. J., THOMPSON H. L. & METCALFE D. D. Mast cell
BOTTAZZI B. see KANKOVA M. adhesion to fibronectin, 478
BouwMaN E. see LJZERMANS J. N. M. Davies E. V., HALLETT M. B. & CAMPBELL A. K. Localized superoxide
BOWERN N. A. see HUNTER N. release by neutrophils can be provoked by a cytosolic calcium ‘cloud’,
BrEEL M. see LimPENs J. 228
BREITTMAYER J.-P., AusseEL C., FARAHIFAR D., Cousin J.-L. & FEHL- Davies M. C. see O' HAGAN D. T.
MANN M. A phosphatidic acid-sensitive intracellular pool of calcium DaviGNON J.-L., VALLIN-DAVIGNON M., COHEN P. L. & EISENBERG R. A.
is released by anti-CD3 in Jurkat T cells, 134 Targeting of T-B interaction using heteroconjugate antibody, |
BricGs S., Price M. R. & TENDLER S. J. B. Immune recognition of linear Davis S. S. see O'HAGAN D. T.
epitopes in peptide fragments of epithelial mucins, 505 De LA FUENTE M., Det Rio M., FERRANDEZ M. D. & HERNANZ A.
BROLIDEN K. see BROLIDEN P. A. Modulation of phagocytic function in murine peritoneal macro-
BROLIDEN P. A., MAKITALO B., AKERBLOM L., ROSEN J., BROLIDEN K.., phages by bombesin, gastrin-releasing peptide and neuromedin C,
Utter G., JonDAL M., Norrsy E. & WAHREN B. Identification of 205
amino acids in the V3 region of gp120 critical for virus neutralization DE BAETSELIER P. see SCHEERLINCK J.-P. Y.
by human HIV-1-specific antibodies, 371 DE BAETSELIER P. see SILEGHEM M.
Brom C., Brom J. & KONIG W. G protein activation and mediator De Bruin R. W. F. see IsZERMANS J. N. M.
release from human neutrophils and platelets after stimulation with Dex Rio M. see DE LA FUENTE M.
sodium fluoride and receptor-mediated stimuli, 287 Dempsey R. A. see Conti P.
Brom J. see Brom C. DIAMANT M. see KAPPEL M.
Brooks C. G. see HOLSCHER M. DimMock N. J. see McLain L.
Brown F. see Francis M. J. D1Ixon G. see WALKER L.
BRYANT A. see FRANZ A. DUCHAINE J. see Mosser D. D.
Brys L. see SCHEERLINCK J.-P. Y.
BueNnaFe A. C. & RITTENBERG M. B. Maturation of the antibody EISENBERG R. A. see DAVIGNON J.-L.
response to a protein-coupled form of the organophosphorus toxin ERMAK T. H. see Pappo J.
soman, 398 Evans G. F. see ZUCKERMAN S. H.
512
Author Index
Ezaki T., MATSUNO K. & KOTANi M. Thymic nurse cells (TNC) in HERNANZ A. see DE LA FUENTE M.
spontaneous thymoma BFU/Mna rats as a model to study their roles HILGER R. A. see NEUBER K.
in T-cell development, 151 Ho P. see NEL A. E.
HOEBEN-SCHORNAGEL K. see LIMPENS J.
Faccioui L. H., NOURSHARGH S., MOQBEL R., WILLIAMS F. M., SEHMI Horuults F. M. A. see VAN DEN BERG C. W.
R., Kay A. B. & Wituiams T. J. The accumulation of !!'In- HOLMDAHL R. see ANDERSSON M.
eosinophils induced by inflammatory mediators, in vivo, 222 HOLMDAHL R. see CARLSTEN H.
FARAHIFAR D. see BREITTMAYER J.-P. HOLSCHER M., GIVAN A. L. & Brooks C. G. The effect of transfected
FARRANT J. see FRANZ A. MHC class I genes on sensitivity to natural killer cells, 44
FEHLMANN M. see BREITTMAYER J.-P. Honc K. see TANAKA E.
FERRANDEZ M. D. see DE LA FUENTE M. Horvat B., POLJAK-BLAZI M. & HaAbuA J. Inhibition of IL-1 activity
FERRANTE A. see PouLos A. induced with allogeneic transformation of UV-irradiated blood, 120
FERREIRA S. H. see RIBEIRO R. A. HOSKING C. S. see COLLINS A. M.
FLANNERY G. R. see COLLINS A. M. HuanG S. K. & MarsH D. G. Human T-cell responses to ragweed
Fiores C. A. see RiBerro R. A. allergens: Amb V homologues, 363
FONTECHA A. M. see NAVARRO R. HumpPureys A. S. see WANG M.-W.
FONTECHA A.-M., ALVAREZ A., NAVARRO R., ZAPATA A. & ARDAVIN C. Hunter N., Weston K. M. & BowerN N. A. Suppression of
Rat thymic cultures: morphological and phenotypical characteriza- experimental allergic encephalomyelitis by «2-macroglobulin, 58
tion, 165 HUTCHINGS P. see CHAMPION B. R.
Francis M. J., HASTINGS G. Z., BROWN F., MCDERMED J., Lu Y.-A. &
Tam J. P. Immunological evaluation of the multiple antigen peptide IJZERMANS J. N. M., BOUWMAN E., DE BRuIN R. W. F., JEEKEL J. &
(MAP) system using the major immunogenic site of foot-and-mouth Maraust R. L. Treatment with rIFN-y has no effect on cardiac
disease virus, 249 allograft rejection, 243
FRANKEN J. see NEUBER K. IkuTA S., Kirpy J. A., SHENTON B. K., GivAN A. L. & LENNARD T. W.
FRANKLIN K. see NEL A. E. M. Human endothelial cells: effect of TNF-x on peripheral blood
FRANZ A., BRYANT A. & FArRRANT J. Interleukin-2-induced DNA mononuclear cell adhesion, 71
synthesis and immunoglobulin secretion by resting human tonsillar B INOUE K. see TANAKA E.
cells: effects of protein kinase C activation, 322 ISHIOKA C. see KIMATA H.
Fricke H., MENDLOvic S., BLANK M., SHOENFELD Y., BEN-BAssAT M. & IsopE K.-I. & NAKASHIMA I. Homotypic aggregation of murine T
Mozes E. Idiotypic specific T-cell lines inducing experimental lymphocytes induced by anti-Thy-1 monoclonal antibodies, 159
systemic lupus erythematosus in mice, 421
FUCHIMOTO S. see MATUSUBARA N. JACHEZ B. see KUNTZ L.
JEEKEL J. see IJZERMANS J. N. M.
Gay S. see SIMON M. M. JEFFERY H. see O'HAGAN D. T.
GERLI R. see SPINOZZ1 F. JONDAL M. see BROLIDEN P. A.
GERMERAAD W. T. V. see LIMPENS J. Jones R. A., RicHarns S. J., PateL D. & Scott C. S. Suppression of
GHADERI A. A. & STANWORTH D. R. Affinity-purified soluble FceRII natural killer cell activity by rabbit antibody to human beta-
CD23 derived from a culture supernatant ofa nE BV-immortalized B- microglobulin (2m) is an Fe-mediated phenomenon and is not B2m
cell line induced a monophasic fever in rabbits, 510 specific, 342
GIENI R. S. see HAYGLASs K. T. JUNG G. see HAUSCHILDT S.
Givan A. L. see HOLSCHER M.
Givan A. L. see IkuTA S. KANKOVA M., LuINI W., PEDRAZZONI M., RIGANTI F., SiRONI M.,
Goetz E. J. see BoGGs J. M. BOTTAZZ1 B., MANTOVANI A. & VECCHI A. Impairment of cytokine
GOLDSCHMIDT T. J. see ANDERSSON M. production in mice fed a vitamin D3-deficient diet, 466
GoopInG L. R. see Boss J. M. KAPPEL M., DIAMANT M., HANSEN M. B., KLOKKER M. & PEDERSEN B.
GRIGNANI F. see SPINOZZI F. K. Effects of in vitro hyperthermia on the proliferative response of
GUTHRIE L. see ZUCKERMAN S. H. blood mononuclear cell subsets, and detection of interleukins | and 6,
tumour necrosis factor-alpha and interferon-gamma, 304
Habua J. see HorvAT B. Katz R. see NEL A. E.
HALLETT M. B. see Davies E. V. Kay A. B. see Faccioui L. H.
HANAFUSA T. see OTSUKA A. KEHOE M. A. see Qasim W.
HANSEN M. B. see KAPPEL M. KENNEDY M. W., Wassom D. L., MCINTOSH A. E. & THomas J. C. H-2
HANSON L. A. see DAHLGREN U. I. H. (I-A) control of the antibody repertoire to secreted antigens of
Harpy S. J. see PouLos A. Trichinella spiralis in infection and its relevance to resistance and
Harvey D. P. see PouLos A. susceptibility, 36
Hasui O. H. & Hassan H. Actions oft hree clostridial IgA proteases on KERR M. A. see STEWART W. W.
distinct forms of immunoglobulin A molecules, 235 KIERSZENBAUM F. see SZTEIN M. B.
Hassan H. see Hasuim O. H. KiIMATA H., YosHipa A., IsHIOoKA C. & Mikawa H. Disodium
HastinGs G. Z. see FRANCIS M. J. cromoglycate enhances ongoing immunoglobulin production in vitro
Hauscuitpt S., LUCKHOFF A., LANGHORNE J., WIESMULLER K.-H., in human B cells, 31
JUNG G., BESSLER W. & CamBier J.C. Increase in the intracellular free Kimoto T. see SADAHIRA Y.
calcium concentration is not an obligatory early event in lipopeptide- KINOSHITA T. see TANAKA E.
induced B-cell activation, 366 Kirby J. A. see Ikuta S.
HAUSER P. see SCHEERLINCK J.-P. Y. KLOKKER M. see KAPPEL M.
HayG1ass K. T. & STEFURA W. Antigen-specific modulation of murine KOLB H. see MarTIN S.
IgE and IgG2a responses with glutaraldehyde-polymerized allergen is KOLSCH E. see AUSTRUP F.
independent of MHC haplotype and Igh allotype, 24 KONIG W. see Brom C.
HayG ass K. T., GiENi R. S. & STEFURA W. P. Long-lived reciprocal KONIG W. see NEUBER K.
regulation of antigen-specific IgE and IgG2a responses in mice treated KONIG W. see NEUBER K.
with glutaraldehyde-polymerized ovalbumin, 407 KONIG W. see RAULF M.
HAZENBERG M. A. J. see VAN DEN BERG C. W. Kono N. see OTSUKA A.
HENDERSON D. J., NAYA I., BUNDICK R. V., SMITH G. M. & SCHMIDT J. KOnTSEK P., BoRECKY L., NovAK M., KONTSEKOVA E. & MACiKOovA I.
A. Comparison of the effects of FK-506, cyclosporin A and Enhancement of neutralizing efficacy by combining three monoclonal
rapamycin on IL-2 production, 316 antibodies to human interferon-alpha, 8
514 Author Index
KONTSEKOVA E. see KONTSEK P. Mosser D. D., DucHaine J. & Martin L. H. Biochemical and
Koo C. H. see BoGGs J. M. developmental characterization of the murine cluster of differentia-
Kosco M. H. see BURTON G. F. tion | antigen, 298
Kotani M. see Ezaki T. MOouUNTFORD A. P. see PEMBERTON R. M.
Kovacs W. J. see OLSEN N. J. Mozes E. see FRICKE H.
KoOZONO H. see TANAKA E. Murray A. W. see PouLos A.
KRAAL G. see LiMPENs J.
KRAMER M. D. see SIMON M. M. NAKASHIMA I. see IsoBE K.-I.
KRAMNIK I. B. see APT A. S. NAVARRO R., ARDAVIN C., FONTECHA A. M., ALVAREZ A. & ZAPATA A.
KUCHARZIK T. see AUSTRUP F. In vitro characterization of rat thymic macrophages, 114
Kuntz L., MONTECINO-RODRIGUEZ E., JACHEZ B., ROMAN D. & Loor NAVARRO R. see FONTECHA A.-M.
F. Adoptive transfer of viable motheaten pathology in sublethally Naya I. see HENDERSON D. J.
irradiated beige recipient mice, 356 Nev A. E., LEDBETTER J. A., WiLLiaMs K., Ho P., AKERLEY B.,
FRANKLIN K. & Katz R. Activation of MAP-2 kinase activity by the
Lanpay A. L. see SPEAR G. T. CD? receptor in Jurkat T cells can be reversed by CD45 phosphatase,
LANGHORNE J. see HAUSCHILDT S. 129
LARSSON A. see ANDERSSON M. NeuBer K., HitcGer R. A. & KONIG W. Interleukin-3, interleukin-8,
LasTER S. M. see Boss J. M. FMLP and CSa enhance the release of leukotrienes from neutrophils
LECHLER R. I. see MASON P. D. of patients with atopic dermatitis, 83
LEDBETTER J. A. see NEL A. E. NEUBER K., STEPHAN U., FRANKEN J. & KONIG W. Staphylococcus
LENNARD T. W. M. see IkuTA S. aureus modifies the cytokine-induced immunoglobulin synthesis and
Leu R. W. see CHANG N.-S. CD23 expression in patients with atopic dermatitis, 197
LimPENS J.. VAN MEVER M., VAN SANTEN H. M., GERMERAAD W. T. V., Norrsy E. see BROLIDEN P. A.
HOEBEN-SCHORNAGEL K., BREEL M., SCHEPER R. J. & KRAAL G. NoOuRSHARGH 8S. see Facciout L. H.
Alterations in dendritic cell phenotype and function associated with Novak M. see KONTSEK P.
immunoenhancing effects of a subcutaneously administered cyclo-
phosphamide derivative, 255 O’HaGaN D. T., RAHMAN D., McGee J. P., JEFFERY H., Davies M. C.,
Lint T. F. see SPEAR G. T. WiLuiaMs P., Davis S. S. & CHALLACOMBE S. J. Biodegradable
Liu L. M. & MacPHerSON G. F. Lymph-bourne (veiled) dendritic cells microparticles as controlled release antigen delivery systems, 239
can acquire and present intestinally administered antigens, 281 OLSEN N. J., WATSON M. B. & Kovacs W. J. Studies of immunological
LomBARD! G. see MASON P. D. function in mice with defective androgen action. Distinction between
Loor F. see KUNTZ L. alterations in immune function due to hormonal insensitivity and
Lorini M. see TEDESCHI A. alterations due to other genetic factors, 52
Lowrie D. B. see WALKER L. Orta K. see MATUSUBARA N.
Lu Y.-A. see Francis M. J. OtsuKA A., HANAFUSA T., Kono N. & Tarut S. Lipopolysaccharide
LickuHorF A. see HAUSCHILDT S. augments HLA-A,B,C molecule expression but inhibits interferon-
Luini W. see KANKOVA M. gamma-induced HLA-DR molecule expression on cultured human
endothelial cells, 428
MACIKOVA I. see KONTSEK P.
MAcPHERSON G. F. see Liu L. M. PAGE K. see CHAMPION B. R.
MAKITALO B. see BROLIDEN P. A PANARA M. R. see Conti P.
MANTOVANI A. see KANKOVA M. Pappo J., ERMAK T. H. & STEGER H. J. Monoclonal antibody-directed
MARQUET R. L. see ISZERMANS J. N. M. targeting of fluorescent polystyrene microspheres to Peyer’s patch M
MarsH D. G. see HUANG S. K. cells, 277
MartTIN L. H. see Mosser D. D. PATEL D. see JONES R. A.
MartTIN S., ROTHE H., TscHOpE D., SCHwipPpERT B. & Kors H. PEDERSEN B. K. see KAPPEL M.
Decreased expression of adhesion molecules on monocytes in recent PEDRAZZONI M. see KANKOVA M.
onset IDDM, 123 PEMBERTON R. M., SMYTHIES L. E., MOUNTFORD A. P. & WILSON R. A.
Mason P. D., Lomparpi G. & LECHLER R. I. NK cells inhibit T-cell Patterns of cytokine production and proliferation by T lymphocytes
responses: LFA3* but not LFA3~ T-cell responses are suppressed, differ in mice vaccinated or infected with Schistosoma mansoni, 327
444 Pinto L., Covas M. J. & Victorino R. M. M. Loss of CD45RA and
MATSUNO K. see Ezaki T. gain of CD45RO after in vitro activation of lymphocytes from HIV-
MATUSUBARA N., FucHimoto S. & Orita K. Tumour necrosis factor- infected patients, 147
alpha induces translocation of protein kinase C in tumour necrosis PockLey A. G. & Montcomery P. C. Jn vivo adjuvant effect of
factor-sensitive cell lines, 457 interleukins 5 and 6 on rat tear IgA antibody responses, 19
MCcCDERMED J. see FRANCIS M. J. POLJAK-BLAZI M. see Horvat B.
McGee J. P. see O HAGAN D. T. PouLos A., ROBINSON B. S., FERRANTE A., HARVEY D. P., HARDy S. J. &
MCINTOSH A. E. see KENNEDY M. W. Murray A. W. Effect of 22-32 carbon n-3 polyunsaturated fatty
McLain L. & Dimmock N. J. An influenza haemagglutinin-specific 1gG acids on superoxide production in human neutrophils: synergism of
enhances class | MHC-restricted CTL killing in vitro, 12 docosahexaenoic acid with f-met-leu-phe and phorbol ester, 102
MENDLOvIC S. see FRICKE H. PRESTER M. see SIMON M. M.
MetTcacre D. D. see Dastycu J. Price M. R. see BrRiGGs S.
MIADONNA A. see TEDESCHI A.
MICHAELSSON E. see ANDERSSON M. Qasim W., KEHOE M. A. & Rosinson J. H. Does staphylococcal
MICHEL A. see SCHEERLINCK J.-P. Y. enterotoxin B bind directly to murine T cells?, 433
MIDTVEDT T. see DAHLGREN U. I. H.
Mier J. W. see Conti P. RAHMAN D. see O'HAGAN D. T.
MIKAWA H. see KimaTA H. RAULF M. & KONIG W. Modulation of leukotriene generation from
MILTENBURG L. A. M. see VAN StruP J. A. G. human polymorphonuclear granulocytes by polychlorinated biphe-
MONTECINO-RODRIGUEZ E. see KUNTZ L. nyls (PCB), 485
MontGomery P. C. see PocKLey A. G. RAYFIELD L. S., SUNDARAM K. K. & Situ T. A. Erythrocyte-reactive T-
Moose R. see Faccioii L. H. cell lines and clones from normal mice recognize serum-derived
Moroz A. M. see Apt A. S. antigens, 438
Author Index SES
RAYNER D. C. see CHAMPION B. R. brucei rhodesiense that prevents progression of activated human T
REALE M. see Conti P. lymphocytes through the cell cycle, 180
Ripeiro R. A., FLores C. A., CUNHA F. Q. & FERREIRA S. H. IL-8 causes
in vivo neutrophil migration by a cell-dependent mechanism, 472 TAKATA Y. see TANAKA E.
RICHARDSs S. J. see JONES R. A. TAKEDA J. see TANAKA E.
RIGANTI F. see KANKOVA M. TAKEFMAN D. M. see SPEAR G. T.
RIGLEY K. P. see Smitu S. H. Tam J. P. see Francis M. J.
Riott I. M. see CHAMPION B. R. TANAKA E., HONG K., KINOSHITA T., TAKATA Y., KOZONO H., TAKEDA
RITTENBERG M. B. see BUENAFE A. C. J., YODEN A. & INOUE K. Murine monoclonal anti-Ba antibody that
ROBERTON D. M. see COLLins A. M. enhances haemolytic activity of factor B, 383
ROBINSON B. S. see POULOs A. TARKOWSKI A. see CARLSTEN H.
ROBINSON J. H. see Qasim W. Tarul S. see OTSUKA A.
RoMAN D. see KUNTZ L. TaussiG M. J. see WANG M.-W.
RONCAROLO M. G. see TEDESCHI A. TEDESCHI A., RONCAROLO M. G., LoriINI M. & MIADONNA A. Low MW
RONDONI F. see SPINOZZ1 F. B-cell growth factor potentiates histamine release from human
ROsEN J. see BROLIDEN P. A. basophil leucocytes, 217
ROTHE H. see MARTIN S. TENDLER S. J. B. see BRiGGs S.
Tew J. G. see BURTON G. F.
SADAHIRA Y., YASUDA T. & KimoTo T. Regulation of Forssman antigen Tuomas J. C. see KENNEDY M. W.
expression during maturation of mouse stromal macrophages in THOMPSON H. L. see Dastycu J.
haematopoietic foci, 498 Tite J. see CHAMPION B. R.
Sarawak S. R., YANG C.-P. & BELL E. B. T-cell receptor-bearing cells ToL M. E. VAN Der see VAN StRUP J. A. G.
from athymic nude rats respond to alloantigen in vitro but are TscHOPE D. see MARTIN S.
defective in vivo, 334
SAUNDERS K. see WALKER L. UTTER G. see BROLIDEN P. A.
SCALISE F. see SPINOZZ1 F.
SCHEERLINCK J.-P. Y., BURSSENS G., BRS L., MICHEL A., HAUSER P. & VALLIN-DAVIGNON M. see DAVIGNON J.-L.
De BAETSELIER P. Differential presentation of hepatitis B S-preS(2) VAN DEN BERG C. W., HAZENBERG M. A. J., HorHuis F. M. A.,
particles and peptides by macrophages and B-cell like antigen- VAN Rooyen S. M. & VAN Duk H. C3- and T-cell-dependent
presenting cells, 88 adjuvant activity of in vivo formed immune complexes, 264
SCHEPER R. J. see LIMPENS J. VaN Der Tot M. E. see VAN StruP J. A. G.
ScumiptT J. A. see HENDERSON D. J.
VAN Duk H. see VAN DEN BERG C. W.
SCHWIPPERT B. see MARTIN S. VAN KESSEL K. P. M. see VAN StruP J. A. G.
Scott C. S. see Jones R. A. VAN MEUER M. see LIMPENS J.
SEHMI R. see FAccIo.i L. H. VAN Rooyen S. M. see VAN DEN BERG C. W.
SHENTON B. K. see IkuTA S. VAN SANTEN H. M. see LimpENs J.
SHOENFELD Y. see FRICKE H.
VAN Strup J. A. G., VAN Der Tot M. E., MILTENBURG L. A. M.,
SILEGHEM M., Darst A. & De BAETSELIER P. Jn vitro simulation of
VAN KEssEL K. P. M. & VERHOEF J. Tumour necrosis factor triggers
immunosuppression caused by Trypanosoma brucei, 246
granulocytes to internalize complement-coated virus particles, 77
Simon M. M., KRAMER M. D., PRESTER M. & Gay S. Mouse T-cell
VeccHi A. see KANKOVA M.
associated serine proteinase | degrades collagen type IV: a structural
VERHOEF J. see VAN StruP J. A. G.
basis for the migration of lymphocytes through vascular basement
VICTORINO R. M. M. see PINTO L.
membranes, 117
Sims M. J. see WANG M.-W.
SiRONI M. see KANKOVA M. WAHREN B. see BROLIDEN P. A.
SMITH G. M. see HENDERSON D. J. WALKER L., Lowrie D. B., BARCLAY R., DixON G., SAUNDERS K. &
Situ S. H., RIGLEY K. P. & CALLARD R. E. Activation of human B cells ANDREW P. W. Activation of mouse peritoneal macrophages by
through the CD19 surface antigen results in homotypic adhesion by maintenance in serum-free medium, 109
LFA-1!-dependent and -independent mechanisms, 293 WanG M.-W., Sims M. J., SYMINGTON P. R., HumpuHrReys A. S. &
SmiTH T. A. see RAYFIELD L. S. TaussiGc M. J. Induction of anti-progesterone immunity and preg-
SMyYTHIES L. E. see PEMBERTON R. M. nancy blocking by anti-progesterone anti-idiotypes. Variable efficacy
SPEAR G. T., SULLIVAN B. L., TAKEFMAN D. M., LANDAY A. L. & LINTT. of polyclonal Ab2 antibodies directed against a panel of closely
F. Human immunodeficiency virus (HIV)-infected cells and free virus related Abl antibodies, 348
directly activate the classical complement pathway in rabbit, mouse Wassom D. L. see KENNEDY M. W.
and guinea-pig sera; activation results in virus neutralization by WATSON M. B. see OLSEN N. J.
virolysis, 377 WESTON K. M. see HUNTER N.
Spinozzi F., Bertotto A., RONDONI F., GERLI R., SCALISE F. & WIESMULLER K.-H. see HAUSCHILDT S.
GRIGNANI F. T-lymphocyte activation pathways in alcoholic liver WILLIAMS F. M. see Faccioui L. H.
disease, 140 WILLIAMS K. see NEL A. E.
STANWORTH D. R. see GHADERI A. A. WILLIAMS P. see O'HAGAN D. T.
StarKEY P. M. Expression on cells of early human pregnancy decidua, WILLIAMS T. J. see Faccioui L. H.
of the p75, IL-2 and p145, IL-4 receptors, 64 WILSON R. A. see PEMBERTON R. M.
STEFURA W. P. see HAyGtass K. T. WoLp A. E. see DAHLGREN U. I. H.
STEFURA W. see HayG ass K. T.
STEGER H. J. see Pappo J. YANG C.-P. see SARAWAR S. R.
STEPHAN U. see NEUBER K. YASUDA T. see SADAHIRA Y.
STEWART W. W. & KERR M. A. The measurement of respiratory burst YODEN A. see TANAKA E.
induced in polymorphonuclear neutrophils by IgA and IgG anti- YOSHIDA A. see KIMATA H.
gliadin antibodies isolated from coeliac serum, 491
SULLIVAN B. L. see SPEAR G. T. ZAPATA A. see FONTECHA A.-M.
SUNDARAM K. K. see RAYFIELD L. S. ZAPATA A. see NAVARRO R.
SYMINGTON P. R. see WANG M.-W. ZuCKERMAN S. H., Evans G. F. & GuTHRIE L. Transcriptional and post-
SZAKAL A. K. see BURTON G. F. transcriptional mechanisms involved in the differential expression of
SzTEIN M. B. & KiERSZENBAUM F. A soluble factor from Trypanosoma LPS-induced IL-1 and TNF mRNA, 460
ADONIS 001928059100193C
Subject Index
%2-macroglobulin: Forssman antigen:
suppression in experimental allergic encephalomyelitis, 58 expression, 498
Adhesion, homotypic:
of human B cells induced with anti-CD19, 293 G protein activation and mediator release:
Adhesion molecules: from human neutrophils and platelets, 287
in insulin-dependent diabetes, 123
Adjuvant activity: Hepatitis B S-preS(2) particles and peptides:
of immune complexes, 264 antigen presentation, 88
Alcoholic liver disease: Heteroconjugate antibody-induced T-B interaction, |
T-lymphocyte activation, 140 Human immunodeficiency virus:
Androgen action, mice with defective: neutralizing epitope in V3 of gp120, 371
immunological function, 52 Human immunodeficiency virus-infected cells and virus:
Antibody response to the toxin soman: activation of classical complement pathway, 377
maturation of, 398 Hyperthermia:
Anti-idiotypes, anti-progesterone: effects on lymphoid cells in vitro, 304
induction of immunity and pregnancy blocking, 348
Iccosomes
B-cell activation, lipopeptide induced: and the secondary antibody response, 271
role of intracellular free calcium, 366 Idiotypic T-cell lines:
B-cell growth factor: induction of systemic lupus erythematosus in mice, 421
and histamine release, 217 Immune complexes:
adjuvant activity, 264
Immunoglobulin A:
Cl inhibitor:
action of clostridial proteases on, 235
characterization, 95
Immunoglobulin E and IgG2a antibody responses:
Calcium:
regulation of, 407
phosphatidic acid-sensitive pool, released by anti-CD3, 134
Immunoglobulin E and IgG2a responses:
Calcium store:
antigen-specific modulation, 24
release in neutrophils, 228
Immunoglobulin G, influenza haemagglutinin-specific:
CD1, mouse:
enhancement of cytotoxic T-lymphocyte killing in vivo, 12
biochemical and developmental characterization, 298
Immunoglobulin production:
CD2 receptor:
enhancement by disodium cromoglycate, 31
activation of MAP-2 kinase, 129
Interferon-gamma:
CD23, purified:
neutralization by monoclonal antibodies, 8
from Epstein-Barr virus-immortalized B-cell line, 510
Interferon-gamma, recombinant:
CD45RA and CD45RO:
no effect on allograft rejection, 243
changes in lymphocytes from HIV-infected patients, 147
Interleukin-1 activity:
Coeliac disease:
inhibition with allogeneic UV-irradiated blood, 120
anti-gliadin antibodies in, 491
Interleukin-2 production:
Cremophor EL:
effect of immunosuppressive drugs, 316
adjuvant effect on immunoglobulin class switch, 508
Interleukin-8:
Cytokine production:
effect on neutrophil migration, 472
impairment in vitamin D3-deficient animals, 466
Interleukins 5 and 6:
and T-cell proliferation in S. mansoni-infected or vaccinated mice, 327
adjuvant effect on rat tear IgA, 19
Delayed-type hypersensitivity, in NZB/W F, mice: Leukotriene B4:
genetic control of oestradiol suppression, 186 chemotactic deactivation, 212
Dendritic cell phenotype and function: Leukotriene generation:
effects of cyclophosphamide derivative, 255 modulation by polychlorinated biphenyls, 485
Leukotrienes, release from neutrophils:
Eosinophils, !''In-labelled: enhanced by interleukins 3 and 8, FMLP and CSa, 83
accumulation induced by inflammatory mediators, 222
Escherichia coli: Macrophages, mouse peritoneal:
dietary protein in, antigenicity in gut, 394 activation by maintenance in serum-free medium, 109
Experimental allergic encephalomyelitis: Major histocompatibility complex class I genes, transfected:
suppression by )-macroglobulin, 58 effect on sensitivity to natural killer cells, 44
Major histocompatibility complex control of antibody repertoire to
Factor B: Trichinella, 36
enhancement of haemolytic activity by monoclonal anti-Ba antibody, Major histocompatibility complex expression:
383 effects of lipopolysaccharide on, 428
Fibronectin: MAP-2 kinase:
mast cell adhesion, 478 activation by CD2 receptor, 129
516
Subject Index 517
Mast cell adhesion: Staphylococcus aureus:
to fibronectin, 478 modification of cytokine-induced immunoglobulin synthesis and
Microparticles, biodegradable: CD23 expression, 197
as antigen delivery systems, 239
Motheaten pathology: T-cell aggregation:
adoptive transfer, in beige mice, 356 by anti-Thy-1, 159
Mucins: T cells, human:
immune recognition of linear epitopes, 505 suppression by Trypanosoma brucei rhodesiense, 180
Multiple antigen peptide system: T-cell lines:
immunological evaluation, 249 erythrocyte-reactive from normal mice, 438
T-cell lines and hybridomas, thryroglobulin-specific:
n-3 fatty acids: regulation of autoantibody thryoglobulin production, 415
effects of neutrophil respiratory burst, 102 T-cell receptor-positive cells:
Natural killer activity: in nude rats, 334
suppression by rabbit anti-human /2m antibody, 342 T-cell receptor VB genes and CS:
Natural killer cells: in collagen arthritis, 191
inhibition of T-cell responses, 444 T-cell responses, human:
Natural killer cells, human: to ragweed antigens, 363
activation by lipopolysaccharide, 450 T-lymphocyte activation:
in alcoholic liver disease, 140
Oral immunization: Thymic cultures, rat:
with xenogeneic antibodies, 388 characterization, 165
Thymic macrophages, rat:
in vitro characterization, 114
Peyer’s patch M cells:
Thymic nurse cells:
targeting of microspheres to, 277
in thymoma, 151
Phagocyte function: Trypanosoma brucei:
murine macrophages, modulation by bombesin, gastrin-releasing simulation of immunosuppression, 246
peptide and neuromedin C, 205 Tuberculosis, experimental:
Pregnancy decidua, early: regulation of T-cell responses by lung cells, 173
expression of interleukin-2 and interleukin-4 receptor proteins, 64 Tumour necrosis factor:
Protein kinase C activation: triggering of complement receptor-mediated phagocytosis, 77
effects on interleukin-2-induced DNA synthesis and immunoglobulin Tumour necrosis factor and interleukin-1:
secretion, 322 mechanisms of differential expression, 460
Tumour necrosis factor-alpha:
Respiratory burst, neutrophil: activation of protein kinase C, 457
effect of n-3 fatty acids, 102 on human endothelial cells, 71
Tumour necrosis factor-mediated cytolysis:
Serine proteinase 1, mouse T-cell-associated: sensitivity to, 309
degradation of type IV collagen, 117
Staphylococcal enterotoxin B: Veiled dendritic cells:
and T-cell activation, 433 acquire and present intestinally administered antigens, 281